{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T21:49:04Z","timestamp":1788990544583,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T00:00:00Z","timestamp":1536969600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brazilian Journal of Anesthesiology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.bjan.2018.09.005","type":"journal-article","created":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T05:16:55Z","timestamp":1541481415000},"page":"64-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Efeitos do sulfato de magn\u00e9sio e da milrinona sobre o vasoespasmo cerebral ap\u00f3s hemorragia subaracnoidea por aneurisma: estudo rand\u00f4mico"],"prefix":"10.1016","volume":"69","author":[{"given":"Rabie","family":"Soliman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gomaa","family":"Zohry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjan.2018.09.005_bib0180","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1227\/01.NEU.0000156644.45384.92","article-title":"Prediction of cerebral vasospasm in patients presenting with aneurysmal subarachnoid haemorrhage: a review","volume":"56","author":"Harrod","year":"2005","journal-title":"Neurosurgery"},{"key":"10.1016\/j.bjan.2018.09.005_bib0185","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1385\/NCC:4:1:068","article-title":"Triple\u2010H therapy for cerebral vasospasm following subarachnoid haemorrhage","volume":"4","author":"Lee","year":"2006","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.bjan.2018.09.005_bib0190","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1161\/01.STR.0000160801.96998.57","article-title":"Magnesium sulfate in aneurysmal subarachnoid haemorrhage: a randomized controlled trial","volume":"36","author":"van den Bergh","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.bjan.2018.09.005_bib0195","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3171\/jns.2006.105.5.723","article-title":"Magnesium infusion for vasospasm prophylaxis after subarachnoid haemorrhage","volume":"105","author":"Stippler","year":"2006","journal-title":"J Neurosurg"},{"key":"10.1016\/j.bjan.2018.09.005_bib0200","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0006-3495(90)82626-6","article-title":"Voltage\u2010dependent block by intracellular Mg2+ of N\u2010methyl\u2010d\u2010aspartate\u2010activated channels","volume":"57","author":"Johnson","year":"1990","journal-title":"Biophys J"},{"key":"10.1016\/j.bjan.2018.09.005_bib0205","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1227\/01.NEU.0000043984.42487.0E","article-title":"Hypomagnesemia after aneurysmal subarachnoid haemorrhage","volume":"52","author":"van den Bergh","year":"2003","journal-title":"Neurosurgery"},{"key":"10.1016\/j.bjan.2018.09.005_bib0210","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s11910-010-0134-2","article-title":"Is the magnesium era for aneurysmal subarachnoid haemorrhage over?","volume":"10","author":"Ortega-Gutierrez","year":"2010","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.bjan.2018.09.005_bib0215","first-page":"723","article-title":"Milrinone for the treatment of cerebral vasospasm after subarachnoid haemorrhage: report of seven cases","volume":"48","author":"Arakawa","year":"2001","journal-title":"Neurosurgery"},{"key":"10.1016\/j.bjan.2018.09.005_bib0220","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2176\/nmc.44.393","article-title":"Milrinone reduces cerebral vasospasm after subarachnoid haemorrhage grade IV or V","volume":"44","author":"Arakawa","year":"2004","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"10.1016\/j.bjan.2018.09.005_bib0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1227\/00006123-198001000-00001","article-title":"Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning","volume":"6","author":"Fisher","year":"1980","journal-title":"Neurosurgery"},{"key":"10.1016\/j.bjan.2018.09.005_bib0230","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/1086508X.2009.11079700","article-title":"Transcranial Doppler series part II: performing a transcranial Doppler","volume":"49","author":"Nicoletto","year":"2009","journal-title":"Am J Electroneurodiagn Technol"},{"key":"10.1016\/j.bjan.2018.09.005_bib0235","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1097\/CCM.0b013e3181d9da1e","article-title":"Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid haemorrhage: a randomized, placebo\u2010controlled, clinical study","volume":"38","author":"Westermaier","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.bjan.2018.09.005_bib0240","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1054\/jocn.2001.1039","article-title":"Magnesium: a useful adjunct in the prevention of cerebral vasospasm following aneurysmal subarachnoid haemorrhage","volume":"9","author":"Chia","year":"2002","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.bjan.2018.09.005_bib0245","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.surneu.2007.07.015","article-title":"Magnesium sulfate in the management of patients with aneurysmal subarachnoid haemorrhage: a randomized, placebo\u2010controlled, dose\u2010adapted trial","volume":"69","author":"Muroi","year":"2008","journal-title":"Surg Neurol"},{"key":"10.1016\/j.bjan.2018.09.005_bib0250","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.surneu.2005.11.035","article-title":"Magnesium sulfate: role as possible attenuating factor in vasospasm morbidity","volume":"65","author":"Prevedello","year":"2006","journal-title":"Surg Neurol"},{"key":"10.1016\/j.bjan.2018.09.005_bib0255","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1385\/NCC:3:1:016","article-title":"The safety and feasibility of continuous intravenous magnesium sulfate for prevention of cerebral vasospasm in aneurysmal subarachnoid haemorrhage","volume":"3","author":"Yahia","year":"2005","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.bjan.2018.09.005_bib0260","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.jocn.2009.05.001","article-title":"A meta\u2010analysis of treating subarachnoid haemorrhage with magnesium sulfate","volume":"16","author":"Zhao","year":"2009","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.bjan.2018.09.005_bib0265","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0140-6736(12)60724-7","article-title":"Magnesium for aneurysmal subarachnoid haemorrhage (MASH\u20102): a randomized placebo\u2010controlled trial","volume":"380","author":"Dorhout Mees","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.bjan.2018.09.005_bib0270","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4103\/2152-7806.74147","article-title":"A review of the management of posterior communicating artery aneurysms in the modern era","volume":"1","author":"Golshani","year":"2010","journal-title":"Surg Neurol Int"},{"key":"10.1016\/j.bjan.2018.09.005_bib0275","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3171\/jns.2003.99.1.0015","article-title":"Treatment and outcome in 30 patients with posterior cerebral artery aneurysms","volume":"99","author":"Taylor","year":"2003","journal-title":"J Neurosurg"},{"key":"10.1016\/j.bjan.2018.09.005_bib0280","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3171\/jns.1995.82.5.0791","article-title":"The poor prognosis of ruptured intracranial aneurysms of the posterior circulation","volume":"82","author":"Schievink","year":"1995","journal-title":"J Neurosurg"},{"key":"10.1016\/j.bjan.2018.09.005_bib0285","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jcrc.2012.07.001","article-title":"Prophylactic magnesium for improving neurologic outcome after aneurysmal subarachnoid haemorrhage: systematic review and meta\u2010analysis","volume":"28","author":"Golan","year":"2013","journal-title":"J Crit Care"},{"key":"10.1016\/j.bjan.2018.09.005_bib0290","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/STROKEAHA.109.571125","article-title":"Intravenous magnesium sulphate for aneurysmal subarachnoid haemorrhage (IMASH): a randomized, double\u2010blinded, placebo\u2010controlled, multicenter phase III trial","volume":"41","author":"Wong","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.bjan.2018.09.005_bib0295","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s12028-011-9603-y","article-title":"Magnesium sulfate administration in subarachnoid haemorrhage","volume":"15","author":"Suarez","year":"2011","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.bjan.2018.09.005_bib0300","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s12028-014-9964-0","article-title":"Prophylactic magnesium sulfate for aneurysmal subarachnoid haemorrhage: a systematic review and meta\u2010analysis","volume":"21","author":"Reddy","year":"2014","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.bjan.2018.09.005_bib0305","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0140-6736(12)60724-7","article-title":"Magnesium for aneurysmal subarachnoid haemorrhage (MASH\u20102): a randomized placebo controlled trial","volume":"380","author":"Mees","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.bjan.2018.09.005_bib0310","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/STROKEAHA.107.492447","article-title":"Milrinone for the treatment of cerebral vasospasm after aneurysmal subarachnoid haemorrhage","volume":"39","author":"Fraticelli","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.bjan.2018.09.005_bib0315","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.egja.2013.07.006","article-title":"Effects of milrinone continuous intravenous infusion on global cerebral oxygenation and cerebral vasospasm after cerebral aneurysm surgical clipping","volume":"30","author":"Ghanem","year":"2014","journal-title":"Egyptian J Anaesth"},{"key":"10.1016\/j.bjan.2018.09.005_bib0320","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12028-008-9048-0","article-title":"Milrinone as a rescue therapy for symptomatic refractory cerebral vasospasm in aneurysmal subarachnoid haemorrhage","volume":"11","author":"Romero","year":"2009","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.bjan.2018.09.005_bib0325","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s12028-012-9701-5","article-title":"Milrinone and homeostasis to treat cerebral vasospasm associated with subarachnoid haemorrhage: the Montreal Neurological Hospital Protocol","volume":"16","author":"Lannes","year":"2012","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.bjan.2018.09.005_bib0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2193-1801-3-633","article-title":"The use of intravenous milrinone to treat cerebral vasospasm following traumatic subarachnoid haemorrhage","volume":"3","author":"Lasry","year":"2014","journal-title":"Springerplus"},{"key":"10.1016\/j.bjan.2018.09.005_bib0335","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00234-010-0720-7","article-title":"Angiographic evaluation of the effect of intra\u2010arterial milrinone therapy in patients with vasospasm from aneurysmal subarachnoid haemorrhage","volume":"53","author":"Shankar","year":"2011","journal-title":"Neuroradiology"},{"key":"10.1016\/j.bjan.2018.09.005_bib0340","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1526-4610.2008.01211.x","article-title":"Intra\u2010arterial milrinone for reversible cerebral vasoconstriction syndrome","volume":"49","author":"Bouchard","year":"2009","journal-title":"Headache"},{"key":"10.1016\/j.bjan.2018.09.005_bib0345","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1213\/ANE.0b013e3181cc9ed8","article-title":"Haemodynamic management and outcome of patients treated for cerebral vasospasm with intraarterial nicardipine and\/or milrinone","volume":"110","author":"Schmidt","year":"2010","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bjan.2018.09.005_bib0350","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1227\/01.NEU.0000363153.62579.FF","article-title":"Effect of vasodilation by milrinone, a phosphodiesterase III inhibitor, on vasospastic arteries after a subarachnoid haemorrhage in vitro and in vivo: effectiveness of cisternal injection of milrinone","volume":"66","author":"Nishiguchi","year":"2010","journal-title":"Neurosurgery"}],"container-title":["Brazilian Journal of Anesthesiology"],"original-title":[],"language":"pt","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034709418300084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034709418300084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T04:45:31Z","timestamp":1547009131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0034709418300084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0034709418300084"],"URL":"https:\/\/doi.org\/10.1016\/j.bjan.2018.09.005","relation":{},"ISSN":["0034-7094"],"issn-type":[{"value":"0034-7094","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efeitos do sulfato de magn\u00e9sio e da milrinona sobre o vasoespasmo cerebral ap\u00f3s hemorragia subaracnoidea por aneurisma: estudo rand\u00f4mico","name":"articletitle","label":"Article Title"},{"value":"Brazilian Journal of Anesthesiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjan.2018.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.bjane.2018.09.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}